논문 목록
Issue Date Title Journals
2023-10 Model-informed precision dosing in vancomycin treatment Frontiers in Pharmacology
2023-05 Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population European Journal of Pharmaceutical Sciences
2022-12 Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers DRUG DESIGN DEVELOPMENT AND THERAPY
2022-05 A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer Pharmaceutics
2022-04 The Asian Pharmacometrics Network: The historical background, establishment, objectives and roles, and recent activities CPT: Pharmacometrics and Systems Pharmacology
2021-09 Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers Journal of personalized medicine
2021-05 Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real-world Unified Parkinson's Disease Rating Scale CPT: Pharmacometrics and Systems Pharmacology
2021-05 Population pharmacokinetics of primaquine in the Korean population Pharmaceutics
2021-04 Development of a risk scoring system for predicting acute kidney injury after minimally invasive partial and radical nephrectomy: a retrospective study SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2020-07 Chemical Controllable Gene Drive in Drosophila ACS SYNTHETIC BIOLOGY
2020-05 Effects of cytochrome P450 oxidoreductase genotypes on the pharmacokinetics of amlodipine in healthy Korean subjects Molecular Genetics & Genomic Medicine
2020-02 Dynamic predictive model for postoperative nausea and vomiting for intravenous fentanyl patient-controlled analgesia ANAESTHESIA
2019-08 Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling Journal of Clinical Medicine
2019-08 Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly JOURNAL OF PHARMACEUTICAL SCIENCES
2018-12 Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean Men JOURNAL OF PHARMACEUTICAL SCIENCES
2018-11 Model-based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2018-10 An item response theory based integrated model of headache, nausea, photophobia, and phonophobia in migraine patients JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
2018-05 Population pharmacokinetic model of levetiracetam in Korean neonates with seizures INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2018-05 A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy AAPS JOURNAL
2018-01 Mechanistic Model for Blood Pressure and Heart Rate Changes Produced by Telmisartan in Human Beings BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2017-03 Quantitative assessment of food effect on the pharmacokinetics of nano-crystallized megestrol acetate BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2017-02 Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures Korean Journal of Pediatrics
2017-01 A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology YONSEI MEDICAL JOURNAL
2016-12 Quantitative Model for the Blood Pressure Lowering Interaction of Valsartan and Amlodipine BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2016-09 Pharmacokinetics of a nanocrystal-containing megestrol acetate formulation: A Single-Dose, Randomized, Open-Label, 2-Part, 2-Period Crossover Study in Healthy Korean Subjects INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2016-07 Modelling of the Effect of End-Tidal Carbon Dioxide on Cerebral Oxygen Saturation in Beach Chair Position under General Anaesthesia BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
2016-06 Pore dilatation increases the bicarbonate permeability of CFTR, ANO1 and glycine receptor anion channels JOURNAL OF PHYSIOLOGY-LONDON
2015-10 Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2014-12 Population pharmacokinetic analysis of diurnal and seasonal variations of plasma concentrations of cilostazol in healthy volunteers THERAPEUTIC DRUG MONITORING
2014-08 Pharmacokinetic Interaction between Rosuvastatin and Metformin in Healthy Korean Male Volunteers: A Randomized, Open-label, 3-period, Crossover, Multiple-dose Study CLINICAL THERAPEUTICS
2014-08 Pharmacokinetic Interaction between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male Subjects CLINICAL THERAPEUTICS
2014-08 Pharmacokinetic Interaction between Rosuvastatin and Telmisartan in Healthy Korean Male Volunteers: A Randomized, Open-label, Two-period, Crossover, Multiple-dose Study CLINICAL THERAPEUTICS
2014-04 Development of a Pharmacokinetic Interaction Model for Co-administration of Simvastatin and Amlodipine DRUG METABOLISM AND PHARMACOKINETICS
2013-07 Pharmacokinetic Comparison of 2 Fixed-Dose Combination Tablets of Amlodipine and Valsartan in Healthy Male Korean Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Study CLINICAL THERAPEUTICS
2013-07 Pharmacokinetics of Rosuvastatin/Olmesartan Fixed-Dose Combination: A Single-Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Korean Subjects CLINICAL THERAPEUTICS
2013-03 Pharmacokinetic Comparison of an Orally Disintegrating Film Formulation With a Film-Coated Tablet Formulation of Sildenafil in Healthy Korean Subjects: A Randomized, Open-Label, Single-Dose, 2-Period Crossover Study CLINICAL THERAPEUTICS
2012-09 Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2012-08 The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers PHARMACOGENETICS AND GENOMICS
2012-07 The views of patients and healthy volunteers on participation in clinical trials: An exploratory survey study CONTEMPORARY CLINICAL TRIALS
2012-04 A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy INVESTIGATIONAL NEW DRUGS
2011-12 Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study CLINICAL THERAPEUTICS
2011-08 The effect of beta1-adrenergic receptor gene polymorphism on prolongation of corrected QT interval during endotracheal intubation under sevoflurane anesthesia Korean Journal of Anesthesiology
2011-06 Population pharmacokinetics of amikacin in a Korean clinical population INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2011-05 The T2-Shortening Effect of Gadolinium and the Optimal Conditions for Maximizing the CNR for Evaluating the Biliary System: a Phantom Study KOREAN JOURNAL OF RADIOLOGY
2011-03 Rifampin Enhances the Glucose-Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants CLINICAL PHARMACOLOGY & THERAPEUTICS
2011-01 Effect of CYP2B6 Genotype on the Pharmacokinetics of Sibutramine and Active Metabolites in Healthy Subjects JOURNAL OF CLINICAL PHARMACOLOGY
2010-12 PEG-인터페론 알파-2a 제제 DA-3021의 안전성 및 약동력학적 특성 연구 Journal Of Korean Society For Clinical Pharmacology And Therapeutics
2010-10 Modeling the Effect of Sevoflurane on Corrected QT Prolongation A Pharmacodynamic Analysis Anesthesiology
2010-07 A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer Investigational New Drugs
2010-01 Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients Oncology
2010-01 Pharmacokinetic Comparison of Controlled-Release and Immediate-Release Oral Formulations of Simvastatin in Healthy Korean Subjects: A Randomized, Open-Label, Parallel-Group, Single- and Multiple-Dose Study Clinical Therapeutics
2009-12 Nerve growth factor and expression of its receptors in patients with diabetic neuropathy Diabetic Medicine
2009-06 Pharmacokinetic properties and tissue storage of FITC conjugated SA-MnMEIO nanoparticles in mice Current Applied Physics
2009-01 Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma Oncology
2008-02 Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans Clinical Pharmacology & Therapeutics
2007-08 Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2007-01 A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults CLINICAL THERAPEUTICS
2006-08 Bispectral index does not correlate with observer assessment of alertness and sedation scores during 0.5% bupivacaine epidural anesthesia with nitrous oxide sedation ANESTHESIA AND ANALGESIA
2005-01 국내인에서의 항생제 약동학 모델링 : 아미카신의 적용예 감염과화학요법
2000-08 Race and sex influence clearance of nifedipine: Results of a population study CLINICAL PHARMACOLOGY & THERAPEUTICS
1998-03 Passive versus electrotransport-facilitated transdermal absorption of ketorolac CLINICAL PHARMACOLOGY & THERAPEUTICS
1998-01 Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profile Journal of Pharmacokinetics and Biopharmaceutics
1997-11 Pharmacokinetics of saquinavir zidovudine and zalcitabine in combination therapy ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
1997-10 A semiparametric method for describing noisy population pharmacokinetic data Journal of pharmacokinetics and biopharmaceutics
1997-10 Uncertain pharmacokinetic/pharmacodynamic systems: Design estimation and control Control Eng Practice